Skip to Main Content

Author Details

Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
2014
30
22
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37875569Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2024
37875569Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2024
36928815Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2023
36928815Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2023
33405951Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).J Clin Oncol2021
34112699Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.Cancer Discov2021
33405951Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).J Clin Oncol2021
34112699Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.Cancer Discov2021
32296180Germline Elongator mutations in Sonic Hedgehog medulloblastoma.Nature2020
32296180Germline Elongator mutations in Sonic Hedgehog medulloblastoma.Nature2020
33028839Framework for quality assessment of whole genome cancer sequences.Nat Commun2020
33028839Framework for quality assessment of whole genome cancer sequences.Nat Commun2020
30446996Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels.Int J Cancer2019
31802000The molecular landscape of ETMR at diagnosis and relapse.Nature2019
30446996Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels.Int J Cancer2019
30238975Size matters: Dissecting key parameters for panel-based tumor mutational burden analysis.Int J Cancer2019
30653256Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.Int J Cancer2019
31138115TelomereHunter - in silico estimation of telomere content and composition from cancer genomes.BMC Bioinformatics2019
31802000The molecular landscape of ETMR at diagnosis and relapse.Nature2019
30238975Size matters: Dissecting key parameters for panel-based tumor mutational burden analysis.Int J Cancer2019
31138115TelomereHunter - in silico estimation of telomere content and composition from cancer genomes.BMC Bioinformatics2019
30653256Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.Int J Cancer2019
29269125Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.Pathology2018
35135162Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.JCO Precis Oncol2018
30348504Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases.Pathology2018
29489754The landscape of genomic alterations across childhood cancers.Nature2018
29269125Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.Pathology2018
29753700Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.Lancet Oncol2018
29435664Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.Acta Neuropathol2018
29363116EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non-small cell lung cancer.Int J Cancer2018
29778738Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.Lancet Oncol2018
35135162Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.JCO Precis Oncol2018
30348504Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases.Pathology2018
29363116EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non-small cell lung cancer.Int J Cancer2018
29753700Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.Lancet Oncol2018
29778738Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.Lancet Oncol2018
29489754The landscape of genomic alterations across childhood cancers.Nature2018
29435664Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.Acta Neuropathol2018
28726821The whole-genome landscape of medulloblastoma subtypes.Nature2017
28726821The whole-genome landscape of medulloblastoma subtypes.Nature2017
28572216Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer.J Exp Med2017
28474103Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature.Acta Neuropathol2017
28474103Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature.Acta Neuropathol2017
28572216Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer.J Exp Med2017
26919435New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Cell2016
26923874Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.Cancer Cell2016
26919435New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Cell2016
26814967Active medulloblastoma enhancers reveal subgroup-specific cellular origins.Nature2016
26671409Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.Acta Neuropathol2016
27999735Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases.Oncoimmunology2016
  • 1 - 50 of 60

Recommended Authors

Ander Diaz-Navarro
Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo
Career Start Year 2018
Number of shared co-authors 25
Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 2
Bruno M Grande
Simon Fraser University
Career Start Year 2015
Number of shared co-authors 5
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 6
Erica K Barnell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 5
Richard de Borja
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 25
Hiromichi Suzuki
Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 44
Jiguang Wang
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 4
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 16
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 14
Joshua F McMichael
Washington University
Career Start Year 2009
Number of shared co-authors 12
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 4
Adrian M Dubuc
Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 59
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 27
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 15
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 20
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 1
Roel G W Verhaak
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 30
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 30
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 4
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 24
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 14
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 16
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 91
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 16
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 13
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 53
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 38

Collaborators

Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 18
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 16
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 13
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 13
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 12
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 12
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 12
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 10
Matthias Schlesner
University of Augsburg
Co-authored papers 9
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 9
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 9
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers 8
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 8
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 8
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 8
Andreas von Deimling
Co-authored papers 8
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 8
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 8
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 7
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 7
Stephan Wolf
Co-authored papers 7
Sebastian M Waszak
University of California san francisco
Co-authored papers 7
Stefan Rutkowski
University Medical Center Hamburg-Eppendorf
Co-authored papers 7
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers 7
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 7
Anna-Lena Volckmar
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 6
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 6
David Capper
Charite University Medicine Berlin
Co-authored papers 6
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
Giles W Robinson
St. Jude Children's Research Hospital
Co-authored papers 6
Release 1.2